Enzymatica AB: Quarterly report Q3/2025: Strong development in Sweden and continued focus on international expansion

LUND, Sweden, Oct. 30, 2025 /PRNewswire/ -- Third quarter January-September Net sales reached SEK 15,0 (12,6) million. The operating result totaled SEK -8,2 (-6,4) million. Earnings per share, basic and diluted, were SEK -0.03 (-0.04). Cash flow from operating activities totaled SEK -12.2...